NYSE: PMI · Industrial Applications and Services · 4 alerts · CIK 2030617
Share price
$7.24Close, Nov 16
Market cap
$16.9M
Shares outstanding
2.34MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Picard Medical, Inc. filings on SEC EDGAR ↗
Picard Medical, Inc. is a newly public medical device company focused on total artificial heart therapy, reporting 2,661,574 shares outstanding as of November 12, 2026. The filing highlights significant risks including customer concentration, reliance on single-source suppliers, and an explanatory paragraph from its auditors regarding its ability to continue as a going concern.
Picard Medical, Inc. appointed Richard Fang, Ph.D., as its permanent Chief Executive Officer, effective October 28, 2026. Dr. Fang, who has served as Interim CEO since June 2024 and is the current Chairman of the Board, will receive an annual salary of $0.4 million with no new compensation awards granted at this time.
Picard Medical entered into a Warrant Amendment and Exchange Agreement to issue 200,000 shares of common stock in exchange for the surrender and cancellation of existing warrants. The transaction was conducted as a debt-free exchange under Section 3(a)(9) of the Securities Act, effectively discharging all anti-dilution and adjustment rights associated with the original warrants.
Picard Medical $1M Debt Financing with three accredited investors
Picard Medical, Inc. issued three unsecured convertible notes in the aggregate principal amount of $1.0 million to three accredited investors. The notes bear 3.0% interest and mature on September 30, 2027, with a conversion floor price of $4.00 per share. Upon conversion, the company will also issue pre-funded warrants to the holders on a one-for-one basis.